Michael Steinberg
Directeur Général chez Hy BioPharma, Inc.
Profil
Michael Steinberg is currently the Chairman and CEO of Hy BioPharma, Inc. He holds a Master's in Business Administration from New York University.
Postes actifs de Michael Steinberg
| Sociétés | Poste | Début |
|---|---|---|
Hy BioPharma, Inc.
 Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Directeur Général | 22/04/2009 |
Formation de Michael Steinberg
| New York University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hy BioPharma, Inc.
Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Distribution Services |
